GlassScriptPhysician profile
Johnny Nacilla
NPI 1346261526
$23,205.53
in general payments reported to CMS, 2019-2025
84 companies · $3,244 in 2025
The $3,244 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,687 · 2020: $2,681 · 2021: $4,270 · 2022: $3,829 · 2023: $3,519 · 2024: $2,976 · 2025: $3,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,307 · Education: $264 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,307.25 |
| Education | $264.40 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,853.22 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,901.45 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| Pfizer INC. | $1,179.26 | 2019-2025 | |
| Amgen INC. | $1,171.31 | 2019-2024 | Kyprolis, Lumakras, Repatha |
| Janssen Biotech, INC. | $1,139.98 | 2019-2025 | Erleada, Rybrevant, Darzalex |
| E.R. Squibb & Sons, L.L.C. | $968.66 | 2019-2025 | Opdivo, Opdualag |
| Incyte Corporation | $884.29 | 2019-2025 | Jakafi, Pemazyre, Monjuvi |
| Celgene Corporation | $796.82 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Daiichi Sankyo INC. | $774.34 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Lilly USA, LLC | $701.64 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Regeneron Healthcare Solutions, INC. | $583.29 | 2019-2025 | Libtayo |
| Seagen INC. | $572.87 | 2019-2023 | Adcetris, Padcev, Tivdak |
| Genzyme Corporation | $539.20 | 2019-2025 | |
| Genentech USA, INC. | $532.58 | 2019-2025 | Polivy, Tecentriq, Venclexta |
| Glaxosmithkline, LLC. | $501.05 | 2020-2025 | Ojjaara, Blenrep, Jemperli |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.89 | 2020-2025 | |
| Sobi, INC | $459.94 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $426.99 | 2019-2023 | Imbruvica, Epkinly |
| Merck Sharp & Dohme LLC | $349.73 | 2019-2025 | Keytruda, Welireg |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.16 | 2019-2024 | Gilotrif |
| Dova Pharmaceuticals | $265.65 | 2019-2021 | |
| Pharmaessentia USA Corporation | $262.53 | 2023-2025 | Besremi |
| Bayer Healthcare Pharmaceuticals INC. | $213.26 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $209.10 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $207.40 | 2021-2023 | Zepzelca |
| Karyopharm Therapeutics INC. | $205.68 | 2020-2025 | Xpovio |
| Array Biopharma INC | $197.75 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Eisai INC. | $178.21 | 2019-2025 | |
| Stemline Therapeutics INC. | $169.89 | 2023-2025 | Orserdu |
| Sumitomo Pharma America, INC. | $160.67 | 2023-2025 | Orgovyx |
| Aveo Pharmaceuticals, INC. | $148.61 | 2021-2022 | |
| Beigene USA, INC. | $147.96 | 2022-2024 | Brukinsa |
| Tersera Therapeutics LLC | $140.45 | 2023-2025 | Zoladex, Quzyttir, Xermelo |
| Blueprint Medicines Corporation | $138.49 | 2021-2023 | Ayvakit |
| Astellas Pharma US INC | $137.55 | 2021-2025 | Xtandi |
| Emd Serono, INC. | $121.18 | 2019-2025 | Bavencio |
| Gilead Sciences, INC. | $114.86 | 2019-2025 | Trodelvy |
| Kyowa Kirin, INC. | $114.73 | 2019-2025 | Poteligeo |
| Myriad Genetic Laboratories, INC. | $110.75 | 2022-2024 | Precisetumor |
| Puma Biotechnology, INC. | $110.18 | 2019-2025 | Nerlynx |
| Coherus Oncology, INC. | $105.12 | 2020-2024 | |
| Alexion Pharmaceuticals, INC. | $101.61 | 2022-2024 | Ultomiris |
| Taiho Oncology, INC. | $100.32 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $86.91 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Takeda Pharmaceuticals U.S.A., INC. | $79.06 | 2023-2024 | Fruzaqla, Alunbrig |
| Exelixis INC. | $77.20 | 2019-2025 | Cabometyx |
| Adc Therapeutics America, INC. | $76.34 | 2022-2023 | |
| Kite Pharma, INC. | $74.19 | 2022-2025 | Yescarta |
| Acrotech Biopharma INC. | $71.43 | 2021-2023 | Beleodaq |
| Spectrum Pharmaceuticals INC. | $63.43 | 2023-2025 | Rolvedon |
| Beone Medicines USA, INC. | $55.94 | 2025 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $49.38 | 2020-2024 | Monoferric |
| Genmab U.S., INC. | $42.57 | 2023 | Epkinly |
| Geron Corporation | $42.23 | 2025 | Rytelo |
| Tesaro, INC. | $40.61 | 2019 | |
| Partner Therapeutics, INC. | $39.59 | 2019 | |
| Celltrion USA INC. | $35.77 | 2025 | Vegzelma |
| Myovant Sciences INC. | $34.93 | 2021 | |
| Amag Pharmaceuticals, INC. | $28.15 | 2019-2020 | |
| Mirati Therapeutics, INC. | $27.06 | 2023 | Krazati |
| Verastem, INC. | $26.97 | 2019 | |
| Csl Behring | $24.58 | 2023 | Kcentra |
| Organon LLC | $23.98 | 2023 | Ontruzant |
| Agios Pharmaceuticals, INC. | $23.91 | 2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $23.53 | 2021 | |
| Epizyme, INC. | $21.61 | 2021 | |
| Janssen Scientific Affairs, LLC | $20.86 | 2025 | Rybrevant |
| Helsinn Therapeutics (U.S.), INC. | $19.76 | 2019 | |
| Medtronic, INC. | $19.48 | 2024 | Osteocool Rf Ablation System |
| Fennec Pharmaceuticals, INC. | $19.06 | 2025 | Fyarro |
| Ipsen Biopharmaceuticals, INC | $19.01 | 2025 | Somatuline Depot, Onivyde |
| Tg Therapeutics, INC. | $18.87 | 2021 | |
| Servier Pharmaceuticals LLC | $18.03 | 2024 | |
| Octapharma USA, INC. | $17.65 | 2024 | Balfaxar |
| Janssen Pharmaceuticals, INC | $16.76 | 2019 | |
| Acceleron Pharma, INC. | $16.56 | 2021 | |
| Ethicon US, LLC | $16.31 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.05 | 2019 | |
| Adaptive Biotechnologies Corporation | $16.03 | 2023 | Clonoseq |
| Medtronic USA, INC. | $15.81 | 2019 | |
| Secura Bio, INC. | $15.73 | 2020 | |
| Foundation Medicine, INC. | $15.43 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.97 | 2023 | Odomzo, Yonsa |
| Grifols USA, LLC | $14.17 | 2019 |
Drugs and devices associated with these payments
Imfinzi $580Kisqali $388Enhertu $346Scemblix $310Erleada $309Xtandi $305Venclexta $295Jaypirca $274Verzenio $271Jakafi $271Besremi $263Libtayo $252Doptelet $239Imbruvica $225Elrexfio $214Padcev $209Adcetris $209Orgovyx $200Pluvicto $199Inlyta $197Bosulif $191Rybrevant $183Reblozyl $177Ojjaara $170Orserdu $170Calquence $167Gilotrif $167Lorbrena $163Lynparza $162Opdivo $154Braftovi $154Mektovi $151Sarclisa $148Brukinsa $144Darzalex $143Balversa $142Talzenna $142Epkinly $141Akeega $129Polivy $117Opdualag $112Retevmo $110Piqray $109Tasigna $109Vonjo $108Lutathera $108Zepzelca $102Bavencio $102Tecentriq $100Talvey $98.45Tivdak $93.62Promacta $85.91Tukysa $83.69Kyprolis $78.13Precisetumor $77.89Zoladex $76.20Keytruda $69.75Rezlidhia $68.47Tavalisse $68.47Rolvedon $63.43Yescarta $61.42Xalkori $60.03Comirnaty $58.34Elitek $53.84Poteligeo $50.63Fruzaqla $50.60Xpovio $48.12Quzyttir $46.97Ayvakit $45.90Ultomiris $45.47Injectafer $44.96Udenyca $44.67Lenvima $43.49Rytelo $42.23Lunsumio $41.66Paxlovid $39.63Besponsa $39.63Fabhalta $39.30Blenrep $37.87Jemperli $37.11Vegzelma $35.77Trodelvy $35.77Nerlynx $35.50Cabometyx $35.34Monjuvi $33.72Pemazyre $33.72Monoferric $33.58Alunbrig $28.46Gazyva $27.71Krazati $27.06Kcentra $24.58Welireg $24.43Ontruzant $23.98Pyrukynd $23.91Wayrilz $21.95Osteocool Rf Ablation System $19.48Erivedge $19.22Fyarro $19.06Onivyde $19.01Somatuline Depot $19.01
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Nacilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.